FDA inspection
Indiana Blood Center: FDA inspection ending Feb 8, 2006
FDA inspection 412076 · Voluntary Action Indicated (VAI) · Indianapolis, IN
Key facts
| Inspection ID | 412076 |
|---|---|
| Firm | Indiana Blood Center |
| FEI number | 1876571 |
| Address | 8739 US 31 S |
| City | Indianapolis |
| State | IN |
| ZIP | 46227-6252 |
| Fiscal year | 2006 |
| Inspection end date | Feb 8, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation|Blood and Blood Products|New Drug Evaluation |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data